Canopy Growth Corporation·Healthcare
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Healthcare
Drug Manufacturers - Specialty & Generic
1,029
2014-04-07
2.39

In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.07, marking a +1.9% move from the previous day.

Canopy Growth is an important player in the marijuana sector. The stock is trading in penny-stock territory.

Canopy Growth gains attention as marijuana reclassification boosts cannabis sentiment, but margin pressure and execution risks persist.

The company has struggled to improve its business -- and especially to earn a profit. It also has a habit of making dilutive secondary share issues.

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Canopy Growth Corporation (CGC) closed the most recent trading day at $0.98, moving 5.55% from the previous trading session.